Bibliographic record
Levels of circulating semaglutide determine reductions in HbA1c and body weight in people with type 2 diabetes
Overgaard RV, Hertz CL, Ingwersen SH, Navarria A, Drucker DJ. Cell Reports Medicine 2021
§1Bibliographic record
§1.1Record
- Authors
- Overgaard RV, Hertz CL, Ingwersen SH, Navarria A, Drucker DJ
- Title
- Levels of circulating semaglutide determine reductions in HbA1c and body weight in people with type 2 diabetes
- Source
- Cell Reports Medicine
- Year
- 2021
- Volume, issue, pages
- 2(9):100387
- Digital object identifier
- 10.1016/j.xcrm.2021.100387
- PubMed identifier
- 34622226
- Record type
- Journal article
- Institute identifier
- CEI-BR-080
§1.2Institute documents citing this record
Table 1. Documents in the Institute set that cite this record.
| Document | Series |
|---|---|
| Monograph: Semaglutide, oral | Compound monograph |
| Synthesis: Semaglutide, oral in type 2 diabetes mellitus: effect on the anchor… | Evidence synthesis |
| Synthesis: Semaglutide, oral in atherosclerotic cardiovascular disease and… | Evidence synthesis |
| Synthesis: Semaglutide, oral in type 2 diabetes mellitus: tolerability and… | Evidence synthesis |
| Synthesis: Semaglutide, oral in atherosclerotic cardiovascular disease and… | Evidence synthesis |
| Synthesis: Semaglutide, oral in type 2 diabetes mellitus: durability of effect | Evidence synthesis |
| 6 citing documents. | |
§1.3Subject tags
semaglutide exposure-response pharmacokinetics
Compound Evidence Institute · CEI-BR-080 · https://compoundevidence.com/bibliography/overgaard2021/ · retrieved 30 July 2026